Respiratory Syncytial Virus Infections
"Respiratory Syncytial Virus Infections" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Pneumovirus infections caused by the RESPIRATORY SYNCYTIAL VIRUSES. Humans and cattle are most affected but infections in goats and sheep have been reported.
| Descriptor ID |
D018357
|
| MeSH Number(s) |
C02.782.580.600.620.750
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Respiratory Syncytial Virus Infections".
Below are MeSH descriptors whose meaning is more specific than "Respiratory Syncytial Virus Infections".
This graph shows the total number of publications written about "Respiratory Syncytial Virus Infections" by people in this website by year, and whether "Respiratory Syncytial Virus Infections" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 3 | 1 | 4 |
| 1996 | 4 | 0 | 4 |
| 1997 | 2 | 0 | 2 |
| 1998 | 4 | 0 | 4 |
| 1999 | 6 | 1 | 7 |
| 2000 | 3 | 2 | 5 |
| 2001 | 4 | 1 | 5 |
| 2002 | 2 | 0 | 2 |
| 2003 | 7 | 1 | 8 |
| 2004 | 3 | 2 | 5 |
| 2005 | 4 | 1 | 5 |
| 2006 | 2 | 2 | 4 |
| 2007 | 6 | 1 | 7 |
| 2008 | 2 | 0 | 2 |
| 2009 | 5 | 0 | 5 |
| 2010 | 7 | 1 | 8 |
| 2011 | 5 | 0 | 5 |
| 2012 | 6 | 1 | 7 |
| 2013 | 5 | 1 | 6 |
| 2014 | 10 | 2 | 12 |
| 2015 | 10 | 2 | 12 |
| 2016 | 10 | 2 | 12 |
| 2017 | 7 | 2 | 9 |
| 2018 | 8 | 2 | 10 |
| 2019 | 7 | 3 | 10 |
| 2020 | 8 | 1 | 9 |
| 2021 | 12 | 0 | 12 |
| 2022 | 6 | 0 | 6 |
| 2023 | 12 | 0 | 12 |
| 2024 | 8 | 0 | 8 |
| 2025 | 6 | 0 | 6 |
To return to the timeline,
click here.
Below are the most recent publications written about "Respiratory Syncytial Virus Infections" by people in Profiles.
-
Interim Evaluation of Respiratory Syncytial Virus Hospitalization Rates Among Infants and Young Children After Introduction of Respiratory Syncytial Virus Prevention Products - United States, October 2024-February 2025. MMWR Morb Mortal Wkly Rep. 2025 May 08; 74(16):273-281.
-
Mucosal vaccines with STING-agonist liposomal formulations inhibit RSV (respiratory syncytial virus) replication in cotton rats. Vaccine. 2025 May 22; 56:127183.
-
Twenty-five years of palivizumab: a global historic review of its impact on the burden of respiratory syncytial virus disease in children. Expert Rev Anti Infect Ther. 2025 Jun; 23(6):359-378.
-
Coadministration of RSV + influenza or COVID-19 vaccines was noninferior to separate administration for immune responses in adults aged =50 y. Ann Intern Med. 2025 Apr; 178(4):JC41.
-
Patient- and Community-Level Characteristics Associated With Respiratory Syncytial Virus Vaccination. JAMA Netw Open. 2025 Apr 01; 8(4):e252841.
-
Respiratory Syncytial Virus Disease Burden and Nirsevimab Effectiveness in Young Children From 2023-2024. JAMA Pediatr. 2025 Feb 01; 179(2):179-187.
-
Characterizing respiratory syncytial virus (RSV) infections before and during the COVID-19 pandemic. Am J Emerg Med. 2025 Jan; 87:108-112.
-
Infant-derived human nasal organoids exhibit relatively increased susceptibility, epithelial responses, and cytotoxicity during RSV infection. J Infect. 2024 Dec; 89(6):106305.
-
Respiratory Syncytial Virus-Associated Hospitalizations in Children <5 Years: 2016-2022. Pediatrics. 2024 Jul 01; 154(1).
-
Respiratory Syncytial Virus Vaccination in the Adult Pulmonary Patient. Chest. 2024 Nov; 166(5):963-974.